Control of human toxoplasmosis

Area of Science:

• Parasitology
• Zoonotic Diseases
• Infectious Disease Epidemiology

Background:

• Toxoplasmosis is caused by the apicomplexan parasite Toxoplasma gondii, infecting billions worldwide.
• Despite low symptomatic rates, its high prevalence makes it a major zoonotic threat.
• Manifestations include encephalitis, congenital defects, and ocular disease, affecting both immunocompromised and immunocompetent individuals.

Purpose of the Study:

• To review current and future strategies for controlling toxoplasmosis.
• To examine measures targeting various stages of the Toxoplasma gondii life cycle.

Main Methods:

• Review of existing literature on toxoplasmosis control measures.
• Analysis of interventions including education, sanitation, therapeutics, prophylaxis, and vaccines.

Main Results:

• Control strategies encompass public education, food and water safety measures, and biosecurity.
• Therapeutic and prophylactic options target active infections and prevent parasite acquisition.
• Vaccines aim to prevent oocyst shedding in definitive feline hosts.

Conclusions:

• A multi-faceted approach is necessary for effective toxoplasmosis control.
• Interventions targeting parasite transmission, infection, and disease are crucial.
• Future strategies may involve advanced vaccines and improved public health measures.